Skip to main content
. 2019 Dec 18;221(10):1659–1668. doi: 10.1093/infdis/jiz669

Table 3.

Molecular Characteristics in Relation to Resistance Category Among 425 Fecal Escherichia coli Strains

Strain Characteristic No. of Strains (Column %) P Value
Categorya,b,c Trait Total (n = 425f) FQR (n = 77) FQS (n = 348)
Adhesin genes papAH 85 (20) 5 (7) 80 (23) <.001
sfa/focDE 69 (16) 0 (0) 69 (20) <.001
sfaS 21 (5) 0 (0) 21 (6) .01
focG 31 (7) 0 (0) 31 (9) .002
iha 109 (26) 53 (69) 56 (16) <.001
fimH 411 (97) 71 (92) 340 (98) .01
hra 92 (22) 9 (12) 83 (24) .01
yfcV 207 (49) 54 (70) 153 (44) <.001
Toxin genes hlyD 65 (15) 0 (0) 65 (19) <.001
hlyF 30 (7) 0 (0) 30 (9) .002
cnf1 51 (12) 0 (0) 51 (15) <.001
cdtB 27 (6) 0 (0) 27 (8) .004
sat 106 (25) 57 (74) 49 (14) <.001
pic 30 (7) 0 (0) 30 (9) .002
vat 129 (31) 7 (9) 122 (35) <.001
tsh 22 (5) 0 (0) 22 (6) .01
Siderophore genes iroN 96 (23) 0 (0) 96 (28) <.001
fyuA 267 (63) 68 (88) 199 (58) <.001
ireA 41 (10) 2 (3) 39 (11) .01
iutA 134 (32) 59 (77) 75 (22) <.001
chuA 304 (72) 66 (86) 238 (67) .001
Protectin genes K5 42 (10) 24 (31) 18 (5) <.001
iss 27 (6) 0 (0) 27 (8) .004
rfc 23 (5) 0 (0) 23 (7) .009
cvaC 17 (4) 0 (0) 17 (5) .03
traT 183 (43) 45 (58) 138 (40) .002
Miscellaneous virulence genes usp 203 (48) 49 (64) 154 (45) .002
ibeA 65 (15) 2 (3) 63 (18) <.001
ompT 279 (66) 58 (75) 221 (64) .04
H7 fliC 38 (9) 0 (0) 38 (11) <.001
malX 201 (48) 57 (74) 144 (42) <.001
clbB/N 81 (19) 1 (1) 80 (23) <.001
Pathotype (gene combination) ExPEC 178 (42) 45 (58) 133 (38) .001
Phylogroupd B1 60 (14) 5 (7) 55 (16) .03
B2 201 (48) 48 (62) 153 (44) .004
Clonal groupe STc12 21 (5) 0 (0) 21 (6) .02
ST131 61 (15) 39 (51) 22 (6) <.001
ST131-non-H30 20 (5) 1 (1) 19 (5) <.001
ST131-H30 41 (7) 38 (49) 3 (1) .001
ST131-H30Rx 8 (2) 8 (10) 0 (0) .001
ST648 5 (1) 3 (4) 0 (0) .006
ST73 28 (7) 0 (0) 28 (8) .004
STc95 18 (4) 0 (0) 18 (5) .048

Abbreviations: ExPEC, extraintestinal pathogenic Escherichia coli; FQR, fluoroquinolone resistant; FQS, fluoroquinolone susceptible; ST, sequence type; STc, ST complex (group of closely related STs).

aGenes shown are those that yielded P < .05 (by Fisher’s Exact Test) for the 2-group comparison. Boldface, higher prevalence group. Gene definitions: papAH/C/EF/G, P fimbriae; sfa/focDE, S and F1C fimbriae; sfaS, S fimbriae adhesin; focG, F1C fimbriae adhesin; afa/draBC, Dr-binding adhesins; iha, adhesin-siderophore receptor; fimH, type-1 fimbriae adhesin; hra, heat-resistant agglutinin; yfcV, putative chaperone-usher fimbria; hlyD, alpha hemolysin; hlyF, variant hemolysin; cnf1, cytotoxic necrotizing factor 1; cdtB, cytolethal distending toxin; sat, secreted autotransporter toxin; pic, protein associated with intestinal colonization; vat, vacuolating toxin; tsh, temperature-sensitive hemagglutinin; iroN, salmochelin receptor; fyuA, yersiniabactin receptor; ireA, catecholate siderophore receptor; iutA, aerobactin receptor; chuA, heme-binding outer membrane; K5, group 2 capsule variants; iss, increased serum survival; rfc, O4 lipopolysaccharide; cvaC, microcin V; usp, uropathogenic-specific protein; traT, serum resistance-associated; ibeA, invasion of brain endothelium A; ompT, outer membrane protease; H7 fliC, flagellar variant; malX, pathogenicity island marker; clbB/N, colibactin (polyketide) synthesis.

bGenes detected in ≥1 isolate but not yielding P < .05 (% of 425): afa/draBC (Dr-binding adhesins, 3%), gafD (G fimbriae, 1%), astA (enteroaggregative E. coli toxin, 6%), kpsM II (group 2 capsules, 54%), kpsMT III (group 3 capsules, 3%), K2/K100 (group 2 capsule variants, 4%)

cGenes sought but not detected: afaE8, F17, clpG, bmaE (variant mannose-resistant adhesin).

dPhylogroups detected in ≥1 isolate but not yielding P < .05 (% of 425): A (13%): C (.2%), D (18%), E (2%), F (4%). Phylogroup was indeterminate for 1% of isolates.

eClonal groups detected in ≥1 isolate but not yielding P < .05 (% of 425): ST127 (3%), ST141 (3%), ST144 (1%), ST372 (2%), STc405 (2%), STc69/CGA (5%). Each of the 12 clonal groups sought was detected at least in one isolate.

fThe 425 strains were selected to include all strains of interest, all other unique strains from strain-of-interest households, and all strains from the first 62 non-strain-of-interest households.